المؤلفون: A Arias, FJ Alvarez Manceñído, A Martinez Torron, L Macia Rivas, A Calvo, L Visa, ML Limón, G Iglesias Álvarez, A Mariño Méndez, P Pimentel, A Lozano-Blázquez

المصدر: Section 4: Clinical pharmacy services.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cb106b3067fdc6a57ba34a423c92aa16
https://doi.org/10.1136/ejhpharm-2023-eahp.125

المؤلفون: Estevez-Garcia P, Rivera F, Molina-Pinelo S, Benavent M, Gómez J, Ml, Limón, Md, Pastor, Martinez-Perez J, Paz-Ares L, Carnero A, Rocio Garcia-Carbonero

المصدر: Europe PubMed Central

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::46690cbf3e59ca80f7f002b65c758ae3
http://europepmc.org/abstract/med/25730906

المؤلفون: Arias-Martinez A; Doctoral Program in Pharmacy, Universidad de Granada, Barrio Verxeles n°13 2°, CP 27850, Granada, Viveiro, Spain. arantxa.91.am@gmail.com., Martínez de Castro E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Gallego J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain., Arrazubi V; Medical Oncology Department, Hospital Universitario de Navarra, IdiSNA, Pamplona, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC, CB16/12/00398, Madrid, Spain., Fernández Montes A; Medical Oncology Department, Complejo Hospitalario Universitario de Orense, Orense, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, VHIO, Barcelona, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Vidal-Tocino R; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - IBSAL, Salamanca, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Martin Richard M; Medical Oncology Department, Instituto Catalán de Oncología (ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Sauri T; Medical Oncology Department, Hospital Clinic, Barcelona, Spain., Hierro C; Medical Oncology Department, Instituto Catalán de Oncología (ICO)-Badalona, Barcelona; Badalona-Applied Research Group in Oncology (B-ARGO), Badalona, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia-Ciberonc CB16/12/0035, Valencia, Spain., Cerda P; Medical Oncology Department, Hospital Universitario Santa Creu y Sant Pau, Barcelona, Spain., Martínez Moreno E; Medical Oncology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain., Martínez Lago N; Medical Oncology Department, Complejo Hospitalario Universitario de Ferrol, Ferrol, Spain., Mérida-García AJ; Medical Oncology Department, Complejo Asistencial de Zamora, Zamora, Spain., Gómez González L; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., García Navalón FJ; Medical Oncology Department, Hospital Universitario de Son Llatzer, Mallorca, Spain., Ruiz Martín M; Medical Oncology Department, Complejo Asistencial Universitario de Palencia, Palencia, Spain., Marín G; Medical Oncology Department, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain., López-López F; Medical Oncology Department, Hospital Universitario del Sureste, Madrid, Spain., Ruperez Blanco AB; Medical Oncology Department, Hospital Universitario de Toledo, Toledo, Spain., Fernández AF; Medical Oncology Department, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain., Alvarez-Manceñido F; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain.

المصدر: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jul; Vol. 26 (7), pp. 1674-1686. Date of Electronic Publication: 2024 Feb 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Adenocarcinoma*/drug therapy , Adenocarcinoma*/pathology , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/pathology , Fluorouracil*/therapeutic use , Fluorouracil*/administration & dosage , Esophageal Neoplasms*/drug therapy , Esophageal Neoplasms*/pathology , Capecitabine*/therapeutic use , Capecitabine*/administration & dosage , Receptor, ErbB-2*/metabolism , Registries* , Leucovorin*/therapeutic use , Leucovorin*/administration & dosage , Leucovorin*/adverse effects , Oxaliplatin*/therapeutic use , Oxaliplatin*/administration & dosage , Cisplatin*/therapeutic use , Cisplatin*/administration & dosage, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Organoplatinum Compounds/therapeutic use ; Organoplatinum Compounds/administration & dosage ; Progression-Free Survival ; Esophagogastric Junction/pathology ; Aged, 80 and over ; Spain

SCR Protocol: Folfox protocol

المؤلفون: Jiménez-Sánchez A; Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Avda. Manuel Siurot s/n, 41013 Seville, Spain., Pereira-Cunill JL; Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Avda. Manuel Siurot s/n, 41013 Seville, Spain., Limón-Mirón ML; Unidad de Gestión Clínica de Oncología Médica, Hospital Universitario Virgen del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain., López-Ladrón A; Unidad de Gestión Clínica de Oncología Médica, Hospital Universitario Virgen del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain., Salvador-Bofill FJ; Unidad de Gestión Clínica de Oncología Médica, Hospital Universitario Virgen del Rocío, Avda. Manuel Siurot s/n, 41013 Seville, Spain., García-Luna PP; Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Biomedicina de Sevilla, IBiS/Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Avda. Manuel Siurot s/n, 41013 Seville, Spain.

المصدر: Nutrients [Nutrients] 2024 Jun 11; Vol. 16 (12). Date of Electronic Publication: 2024 Jun 11.

نوع المنشور: Journal Article; Validation Study; Comparative Study

بيانات الدورية: Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6643 (Electronic) Linking ISSN: 20726643 NLM ISO Abbreviation: Nutrients Subsets: MEDLINE

مواضيع طبية MeSH: Colorectal Neoplasms*/diagnosis , Electric Impedance* , Nutritional Status*, Humans ; Male ; Female ; Cross-Sectional Studies ; Middle Aged ; Aged ; Reproducibility of Results ; Hand Strength ; Muscle Strength Dynamometer ; Nutrition Assessment ; Adult

المؤلفون: Pérez-Wert P; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Paseo de La Castellana, 261, 28046, Madrid, Spain. pablopwert@gmail.com., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Paseo de La Castellana, 261, 28046, Madrid, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain., Lecumberri A; Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain., Cacho Lavin D; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Losantos García I; Biostatistics Unit, IdiPAZ-Hospital Universitario La Paz, Madrid, Spain., Fernández Montes A; Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Hernández San Gil R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Diez M; Medical Oncology Department, Hospital Universitario Val d´Hebron, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain., Vidal Tocino R; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain., Macías Declara I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Pimentel Cáceres P; Medical Oncology Department, Hospital General Universitario Santa Lucía, Cartagena, Spain., Gil Raga M; Medical Oncology Department, Hospital General Universitario de Valencia, Valencia, Spain., Martínez Moreno E; Medical Oncology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain., Sauri T; Medical Oncology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain., Martín Richard M; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Cerdà P; Medical Oncology Department, Hospital Universitario Santa Creu I Sant Pau, Barcelona, Spain., Gómez González L; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Mérida-García A; Medical Oncology Department, Hospital Universitario de Zamora, Zamora, Spain., Ruiz Martín M; Medical Oncology Department, Hospital Universitario Río Carrión, Palencia, Spain., Gallego J; Medical Oncology Department, Hospital General Universitario of Elche, Elche, Spain.

مؤلفون مشاركون: AGAMENON-SEOM study group

المصدر: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2024 Jan; Vol. 27 (1), pp. 131-145. Date of Electronic Publication: 2023 Nov 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-3305 (Electronic) Linking ISSN: 14363291 NLM ISO Abbreviation: Gastric Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/pathology , Adenocarcinoma*/pathology, Female ; Young Adult ; Humans ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Progression-Free Survival ; Registries

المؤلفون: Valcarcel S; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Avenida Roma Sn., CP 33011, Oviedo, Spain. senavg@gmail.com., Gallego J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., de Castro EM; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Arrazubi V; Medical Oncology Department, Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Montes AF; Medical Oncology Department, Complejo Hospitalario Universitario de Ourense, Orense, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Calvo A; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Tocino RV; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - IBSAL, Salamanca, Spain., Lago NM; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, Coruña, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos Madrid, Madrid, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia, Ciberonc CB16/12/0035, Valencia, Spain., Pimentel P; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain., Macia-Rivas L; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Pérez CH; Medical Oncology Department, Hospital Universitario Nuestra Señora de La Candelaria, Tenerife, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain., Carnicero AM; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Cerdà P; Medical Oncology Department, Hospital Santa Creu I Sant Pau, Barcelona, Spain., Gonzalez LG; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Navalon FG; Medical Oncology Department, Hospital Universitario Son Llatzer, Mallorca, Spain., Rambla MDM; Medical Oncology Department, Hospital Universitario Virgen de La Macarena, Seville, Spain., Richard MM; Medical Oncology Department, Catalan Institute of Oncology (ICO), L'Hospitalet, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, CP13/00126, PI17/0050 (ISCIII& FEDER), Murcia, Spain.

المصدر: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Jul; Vol. 149 (7), pp. 4077-4089. Date of Electronic Publication: 2022 Aug 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/pathology , Adenocarcinoma*/pathology, Humans ; Paclitaxel ; Antibodies, Monoclonal/therapeutic use ; Registries ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Ramucirumab

SCR Disease Name: Adenocarcinoma Of Esophagus

المؤلفون: Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Foy V; Department of Medical Oncology, Christie Hospital, Manchester, UK., Raby S; Department of Medical Oncology, Christie Hospital, Manchester, UK., Carmona-Bayonas A; Medical Oncology Department, Hospital Universitario Morales Meseguer, Calle Marqués de los Vélez, s/n, Murcia 30007, Spain., Macía-Rivas L; Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Arrazubi V; Medical Oncology Department, Complejo Hospitalario de Navarra, IdiSNA (Navarra Institute for Health Research), Pamplona, Spain., Cacho Lavin D; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Hernandez San Gil R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Fernández Montes A; Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain., Mirallas O; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain., Macias Declara I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Vidal Tocino R; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Pimentel P; Medical Oncology Department, Hospital General Universitario Santa Lucía, Cartagena, Spain., Martínez Lago N; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Sauri T; Medical Oncology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain., Martín Richard M; Medical Oncology Department, Catalan Institute of Oncology, Barcelona, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Usansolo, Spain., Gil Raga M; Medical Oncology Department, Hospital General Universitario de Valencia, Valencia, Spain., Calvo A; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Reguera P; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Martín Carnicero A; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Hernández Pérez C; Medical Oncology Department, Hospital Universitario Nuestra Señora de the Candelaria, Santa Cruz de Tenerife, Spain., Cerdá P; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain., Gomez Gonzalez L; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Garcia Navalon F; Medical Oncology Department, Hospital Universitario Son Llatzer, Mallorca, Spain., Pacheco Barcia V; Medical Oncology Department, Hospital Universitario de Torrejón, Madrid, Spain., Gutierrez Abad D; Medical Oncology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain., Ruiz Martín M; Medical Oncology Department, Hospital Universitario Rio Carrión de Zamora, Zamora, Spain., Weaver J; Department of Medical Oncology, Christie Hospital/University of Manchester, Manchester, UK., Mansoor W; Department of Medical Oncology, Christie Hospital/University of Manchester, Manchester, UK., Gallego J; Medical Oncology Department, Hospital General Universitario of Elche, Elche, Spain.

المصدر: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Mar 04; Vol. 15, pp. 17588359231157641. Date of Electronic Publication: 2023 Mar 04 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

المؤلفون: Plazas JG; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain. Electronic address: j.gallegoplazas@gmail.com., Arias-Martinez A; Pharmacy Department, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain., Lecumberri A; Medical Oncology Department, Hospital Universitario de Navarra, Pamplona, Spain., Martínez de Castro E; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Montes AF; Medical Oncology Department, Complejo Hospitalario de Ourense, Ourense, Spain., Macias I; Medical Oncology Department, Hospital Universitario Parc Taulí, Sabadell, Spain., Pieras-Lopez A; Pharmacy Department, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain., Diez M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Tocino RV; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca - ISBAL, Salamanca, Spain., Lago NM; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, Coruña, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Gil M; Medical Oncology Department, Hospital General Universitario de Valencia - Ciberonc CB16/12/0035, Valencia, Spain., Pimentel P; Medical Oncology Department, Hospital Santa Lucía, Cartagena, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Carnicero AM; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Pérez CH; Medical Oncology Department, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain., Gonzalez LG; Medical Oncology Department, Hospital General Universitario de Alicante, Alicante, Spain., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain.

المصدر: ESMO open [ESMO Open] 2022 Jun; Vol. 7 (3), pp. 100514. Date of Electronic Publication: 2022 Jun 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma*/drug therapy , Adenocarcinoma*/epidemiology , Adenocarcinoma*/pathology , Stomach Neoplasms*/drug therapy , Stomach Neoplasms*/epidemiology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Male ; Progression-Free Survival ; Registries

المؤلفون: Alvarez-Manceñido F; Pharmacy Department, Hospital Universitario Central de Asturias, Avenida Roma s/n, 33011, Oviedo, Spain. felipealvarezm@yahoo.es., Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain., Arrazubi V; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Pericay Pijaume C; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Aguado G; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Martínez Lago N; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Sánchez Cánovas M; Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain., Cacho Lavin D; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Martinez-Torron A; Pharmacy Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Arias-Martinez A; Pharmacy Department, Hospital Universitario Central de Asturias, Avenida Roma s/n, 33011, Oviedo, Spain., López F; Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Vidal Tocino R; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain., Fernández Montes A; Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain., Alsina M; Medical Oncology Department, Hospital Universitario Vall d'Hebron, Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain., Pimentel P; Medical Oncology Department, Hospital General Universitario Santa Lucía, Cartagena, Spain., Reguera P; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Martín Carnicero A; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Ramchandani A; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Azkarate A; Medical Oncology Department, Hospital Universitario Son Espases, Mallorca, Spain., Martín Richard M; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain., Serra O; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Spain., Hernández Pérez C; Medical Oncology Department, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain., Hurtado A; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Gil-Negrete A; Medical Oncology Department, Hospital Universitario Donostia, San Sebastián, Spain., Sauri T; Medical Oncology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain., Morales Del Burgo P; Pathology Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Gallego J; Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain.

المصدر: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association [Gastric Cancer] 2021 Jul; Vol. 24 (4), pp. 926-936. Date of Electronic Publication: 2021 Mar 02.

نوع المنشور: Comparative Study; Journal Article; Multicenter Study

بيانات الدورية: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 100886238 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1436-3305 (Electronic) Linking ISSN: 14363291 NLM ISO Abbreviation: Gastric Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Adenocarcinoma/*mortality , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Esophageal Neoplasms/*mortality , Stomach Neoplasms/*mortality, Adenocarcinoma/drug therapy ; Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Esophageal Neoplasms/drug therapy ; Esophageal Neoplasms/pathology ; Esophagogastric Junction/pathology ; Female ; Humans ; Intestines/pathology ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Prognosis ; Progression-Free Survival ; Proportional Hazards Models ; Receptor, ErbB-2/metabolism ; Registries ; Retrospective Studies ; Stomach Neoplasms/drug therapy ; Stomach Neoplasms/pathology ; Trastuzumab/therapeutic use ; Treatment Outcome

المؤلفون: Jimenez-Fonseca P; Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain., Carmona-Bayonas A; Medical Oncology Department, Hospital Universitario Morales Meseguer, Calle Marqués de los Vélez, s/n, Murcia, 30007, Spain., Martinez-Torron A; Pharmacy Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Alsina M; Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona Vall Hebron Institute of Oncology (VHIO), Barcelona, Spain., Custodio A; Medical Oncology Department, Hospital Universitario La Paz, CIBERONC CB16/12/00398, Madrid, Spain., Serra O; Medical Oncology Department, Catalan Institute of Oncology, L'Hospitalet, Spain., Cacho Lavin D; Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain., Limón ML; Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Sauri T; Medical Oncology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain., López F; Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain., Visa L; Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain., Granja M; Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain., Martínez Lago N; Medical Oncology Department, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain., Arrazubi V; Medical Oncology Department, Complejo Hospitalario de Navarra, IdiSNA (Navarra Institute for Health Research), Pamplona, Spain., Vidal Tocino R; Medical Oncology Department, Complejo Asistencial Universitario de Salamanca-IBSAL, Salamanca, Spain., Hernandez R; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain., Aguado G; Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain., Cano JM; Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Martín Carnicero A; Medical Oncology Department, Hospital San Pedro, Logroño, Spain., Mangas M; Medical Oncology Department, Hospital Galdakao-Usansolo, Usansolo, Spain., Pimentel P; Medical Oncology Department, Hospital General Universitario Santa Lucía, Cartagena, Spain., Fernández Montes A; Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain., Macias Declara I; Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain., Longo F; Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain., Ramchandani A; Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain., Martín Richard M; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain., Hurtado A; Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Azkarate A; Medical Oncology Department, Hospital Universitario Son Espases, Mallorca, Spain., Hernández Pérez C; Medical Oncology Department, Hospital Universitario Nuestra Señora de the Candelaria, Tenerife, Spain., Serrano R; Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain., Gallego J; Medical Oncology Department, Hospital General Universitario of Elche, Elche, Spain.

مؤلفون مشاركون: AGAMENON-SEOM study group

المصدر: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2021 Jun 17; Vol. 13, pp. 17588359211019672. Date of Electronic Publication: 2021 Jun 17 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE